Mann JF, Anderson C, Gao P, Gerstein HC, Boehm M, Ryden L, et al
Artificial sweeteners and carbonated drinks are also common culprits
While these issues seem to affect a minority of patients, the financial impact makes them especially frustrating when they occur
The dual action is thought to offer a more balanced metabolic effect than targeting GLP-1 alone, though individual responses can vary
Some plans limit coverage to diabetes diagnoses, while others require prior authorization or deny claims based on BMI thresholds or step-therapy rules
Tesamorelin (GHRH analog for visceral fat), MOTS-C (mitochondrial AMPK activation), and BPC-157 (connective tissue support during caloric restriction) are popular adds